Advances in biocatalytic synthesis of pharmaceutical intermediates
- 1 April 2005
- journal article
- review article
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 9 (2), 188-194
- https://doi.org/10.1016/j.cbpa.2005.02.007
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Chemoenzymatic Synthesis of Building Blocks for Statin Side ChainsAngewandte Chemie International Edition, 2004
- Challenges in the development of an efficient enzymatic process in the pharmaceutical industryTetrahedron: Asymmetry, 2004
- Trends and innovations in industrial biocatalysis for the production of fine chemicalsCurrent Opinion in Biotechnology, 2004
- Development of an efficient, scalable, aldolase-catalyzed process for enantioselective synthesis of statin intermediatesProceedings of the National Academy of Sciences, 2004
- Enzymatic dynamic kinetic resolution of epihalohydrinsTetrahedron: Asymmetry, 2004
- Exploring Nitrilase Sequence Space for Enantioselective CatalysisApplied and Environmental Microbiology, 2004
- Industrial Methods for the Production of Optically Active IntermediatesAngewandte Chemie International Edition, 2004
- Creation of a Productive, Highly Enantioselective Nitrilase through Gene Site Saturation Mutagenesis (GSSM)Journal of the American Chemical Society, 2003
- Chemo‐Enzymatic Approach to Statin Side‐Chain Building BlocksAdvanced Synthesis & Catalysis, 2003
- Enzymatic synthesis of chiral intermediates for pharmaceuticalsJournal of Industrial Microbiology & Biotechnology, 2003